Astrocytic metabolic control of orexinergic activity in the lateral hypothalamus regulates sleep and wake architecture.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39013907.
- Also identified by DOI 10.1038/s41467-024-50166-7 and PMC identifier 11252394.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Neuronal activity undergoes significant changes during vigilance states, accompanied by an accommodation of energy demands. While the astrocyte-neuron lactate shuttle has shown that lactate is the primary energy substrate for sustaining neuronal activity in multiple brain regions, its role in regulating sleep/wake architecture is not fully understood. Here we investigated the involvement of astrocytic lactate supply in maintaining consolidated wakefulness by downregulating, in a cell-specific manner, the expression of monocarboxylate transporters (MCTs) in the lateral hypothalamus of transgenic mice. Our results demonstrate that reduced expression of MCT4 in astrocytes disrupts lactate supply to wake-promoting orexin neurons, impairing wakefulness stability. Additionally, we show that MCT2-mediated lactate uptake is necessary for maintaining tonic firing of orexin neurons and stabilizing wakefulness. Our findings provide both in vivo and in vitro evidence supporting the role of astrocyte-to-orexinergic neuron lactate shuttle in regulating proper sleep/wake stability.
Medical subject headings
- Astrocytes
- Wakefulness
- Orexins
- Sleep
- Monocarboxylic Acid Transporters
- Mice, Transgenic
- Neurons
- Lactic Acid
- Hypothalamic Area, Lateral